Reimagining Innovation: Additive Manufacturing

In the injectable drug-delivery industry, expectations for improved patient experiences with administration and at-home delivery of therapeutic regimens are evolving. Products that combine the drug, its primary packaging, and a delivery system — commonly called combination products — are on the rise. The inclusion and expansion of digital elements in a delivery system can help deliver medical, sensor, and diagnostic information in real-time data streams. Such data can help caregivers provide better overall care, while other digital elements may encourage adherence to therapeutic regimens. Given these trends, additive manufacturing (AM) provides the opening for expansive idea generation and development agility that can lead to improved quality and new opportunities to disrupt the drug-delivery space.